Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Regional Immunology
|
May 1, 1992
Virus-specific T cells in the central nervous system following infection with an avirulent neurotropic mouse hepatitis virus
J S Williamson
Current Pharmaceutical Design
|
March 20, 2001
Helicobacter pylori: current chemotherapy and new targets for drug design
J S Williamson
Current Pharmaceutical Design
|
May 2, 2000
Angiogenesis: new targets for the development of anticancer chemotherapies
M Gourley, J S Williamson
Regional Immunology
|
July 1, 1988
Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens
J S Williamson, J W Streilein
British Journal of Sports Medicine
|
January 25, 2006
Converging evidence for the under-reporting of concussions in youth ice hockey
I J S Williamson, D Goodman
Transplantation
|
March 1, 1989
Induction of delayed hypersensitivity to alloantigens coinjected with Langerhans cells into the anterior chamber of the eye. Abrogation of anterior chamber-associated immune deviation
J S Williamson, J W Streilein
Journal of Virology
|
September 1, 1990
Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells
J S Williamson, S A Stohlman
Annals of the Royal College of Surgeons of England
|
November 2, 2011
Quality of life after treatment of laryngeal carcinoma: a single centre cross-sectional study
J S Williamson, D Ingrams, H Jones
Mini Reviews in Medicinal Chemistry
|
February 18, 2004
Anti-Helicobacter pylori agents. An update
E M F Muri, J S Williamson
International Ophthalmology
|
October 1, 1990
Ocular molecules and cells that regulate immune responses in situ
J W Streilein, S Cousins, J S Williamson
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Regional Immunology
|
May 1, 1992
Virus-specific T cells in the central nervous system following infection with an avirulent neurotropic mouse hepatitis virus
J S Williamson
Current Pharmaceutical Design
|
March 20, 2001
Helicobacter pylori: current chemotherapy and new targets for drug design
J S Williamson
Current Pharmaceutical Design
|
May 2, 2000
Angiogenesis: new targets for the development of anticancer chemotherapies
M Gourley, J S Williamson
Regional Immunology
|
July 1, 1988
Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens
J S Williamson, J W Streilein
British Journal of Sports Medicine
|
January 25, 2006
Converging evidence for the under-reporting of concussions in youth ice hockey
I J S Williamson, D Goodman
Transplantation
|
March 1, 1989
Induction of delayed hypersensitivity to alloantigens coinjected with Langerhans cells into the anterior chamber of the eye. Abrogation of anterior chamber-associated immune deviation
J S Williamson, J W Streilein
Journal of Virology
|
September 1, 1990
Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells
J S Williamson, S A Stohlman
Annals of the Royal College of Surgeons of England
|
November 2, 2011
Quality of life after treatment of laryngeal carcinoma: a single centre cross-sectional study
J S Williamson, D Ingrams, H Jones
Mini Reviews in Medicinal Chemistry
|
February 18, 2004
Anti-Helicobacter pylori agents. An update
E M F Muri, J S Williamson
International Ophthalmology
|
October 1, 1990
Ocular molecules and cells that regulate immune responses in situ
J W Streilein, S Cousins, J S Williamson
Page
of 4